In the WHAT HEALTH !? newsletter, find the latest news that has made the buzz, cutting-edge trends and groundbreaking innovations in the digital health field.
In today’s newsletter :
Swiss excellence continues to shine in the fight against hypertension, even attracting prestigious investors from Silicon Valley.
The Aktiia blood pressure monitoring bracelet has just been backed by Californian venture capital heavyweight Khosla Ventures. With a total of CHF 27 million in funding, the start-up intends to conquer the US market.
At the same time, Biospectal, a Lausanne-based start-up, has just launched its OptiBP application on the Swiss market, which allows blood pressure to be measured by placing a fingertip on the lens of a smartphone.
Using the same non-invasive optical technique developed by CSEM that can detect changes in pressure and volume in blood vessels, these two start-ups have cracked the code, marking a major milestone in the fight against the world’s number one cause of cardiovascular disease and premature death.
>> Find all the latest news in the columns of your weekly
Stay updated on all things in one place!
>> Subscribe here
See you next Thursday!
Your Swiss Digital Health team
